Eric Assénat
Impact in
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 107
- Pancreatic and Hepatic Oncology Research 37
- Colorectal Cancer Treatments and Studies 36
- Cancer Treatment and Pharmacology 13
- Hepatology 66
- Hepatocellular Carcinoma Treatment and Prognosis 60
- Co-authors
- Marc Ychou (55 shared papers)Rosine Guimbaud (12 shared papers)Jean‐Luc Raoul (5 shared papers)Françoise Desseigne (9 shared papers)Christelle de la Fouchardière (12 shared papers)Jean‐Baptiste Bachet (3 shared papers)Michel Ducreux (6 shared papers)Olivier Bouché (8 shared papers)
- Journals
- Journal of Clinical Oncology (29 papers)Annals of Oncology (18 papers)Cancers (8 papers)Journal of Hepatology (8 papers)Digestive and Liver Disease (5 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Eric Assénat
168 papers receiving 10.1k citations
Eric Assénat's Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 7.2k
- Hepatology 1.6k
- Cancer Research 2.7k
- Pulmonary and Respiratory Medicine 2.5k
- Epidemiology 2.0k
Countries citing papers authored by Eric Assénat
This map shows the geographic impact of Eric Assénat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Assénat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Assénat more than expected).
Fields of papers citing papers by Eric Assénat
This network shows the impact of papers produced by Eric Assénat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Assénat. The network helps show where Eric Assénat may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Assénat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer Hit paper breakdown → | 2011 | 5512 |
| 2 | Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib Hit paper breakdown → | 2014 | 449 |
| 3 | 2015 | 284 | |
| 4 | 2019 | 193 | |
| 5 | 2017 | 153 | |
| 6 | 2016 | 140 | |
| 7 | Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma Hit paper breakdown → | 2023 | 136 |
| 8 | 2016 | 136 | |
| 9 | 2016 | 134 | |
| 10 | 2004 | 122 | |
| 11 | 2012 | 103 | |
| 12 | 2018 | 94 | |
| 13 | Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes. | 2001 | 92 |
| 14 | 2008 | 86 | |
| 15 | 2017 | 80 | |
| 16 | 2012 | 79 | |
| 17 | 2018 | 75 | |
| 18 | 2009 | 72 | |
| 19 | 2017 | 70 | |
| 20 | 2013 | 65 |
About Eric Assénat
Eric Assénat is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 176 papers that have together received 10.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (60 papers), Pancreatic and Hepatic Oncology Research (37 papers), Colorectal Cancer Treatments and Studies (36 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers), Cancer Genomics and Diagnostics (26 papers), Liver Disease Diagnosis and Treatment (17 papers), Lung Cancer Treatments and Mutations (15 papers) and Cancer Treatment and Pharmacology (13 papers). The work is most often cited by research in Oncology (7.2k citations), Hepatology (1.6k citations), Cancer Research (2.7k citations), Pulmonary and Respiratory Medicine (2.5k citations) and Epidemiology (2.0k citations). Eric Assénat has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Marc Ychou, Rosine Guimbaud, Jean‐Luc Raoul, Françoise Desseigne, Christelle de la Fouchardière, Jean‐Baptiste Bachet, Michel Ducreux, Olivier Bouché, Y. Bécouarn and Antoine Adenis. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, Journal of Hepatology and Digestive and Liver Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.